DVL1 and hepatocellular carcinoma: Recently, soluble FzD-7 (sFZD7) alone or in combination with doxorubicin has been shown to suppress Wnt signaling through the blockade of interactions between FZD/DVL, which decreasing the expression of Wnt target genes in HCC cells [207].